41 related articles for article (PubMed ID: 2663144)
21. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
22. Immunomagnetic purging of bone marrow: a model for negative cell selection.
Pole JG; Gee A; Janssen W; Lee C; Gross S
Am J Pediatr Hematol Oncol; 1990; 12(3):257-61. PubMed ID: 2240471
[TBL] [Abstract][Full Text] [Related]
23. [Immunocytologic tumor cell detection in bone marrow of breast cancer patients].
Schwarz I; Eichfeld U; Gläser A
Z Arztl Fortbild (Jena); 1992 Oct; 86(19):977-80. PubMed ID: 1441634
[No Abstract] [Full Text] [Related]
24. [Breast neoplasms: micrometastasis].
Kosaka Y; Mimori K; Mori M; Moriyama N; Watanabe M
Nihon Rinsho; 2007 Jun; 65 Suppl 6():47-53. PubMed ID: 17682138
[No Abstract] [Full Text] [Related]
25. [New therapeutic methods with monoclonal antibodies].
Okabe T
Gan No Rinsho; 1989 May; Spec No():189-95. PubMed ID: 2481047
[No Abstract] [Full Text] [Related]
26. Bone marrow purging and processing--a review of ancillary effects.
Gee AP
Prog Clin Biol Res; 1990; 333():507-21. PubMed ID: 2408064
[TBL] [Abstract][Full Text] [Related]
27. The human tumor cloning assay in cancer research and therapy: a review with clinical correlations.
Hanauske AR; Hanauske U; Von Hoff DD
Curr Probl Cancer; 1985 Dec; 9(12):1-66. PubMed ID: 2419036
[No Abstract] [Full Text] [Related]
28. Low antigen density tumor cells: an obstacle to effective autologous bone marrow purging?
Boyle MD; Gee AP
Cancer Invest; 1987; 5(2):113-8. PubMed ID: 3300891
[TBL] [Abstract][Full Text] [Related]
29. Design of large-scale separation systems for positive and negative immunomagnetic selection of cells using superparamagnetic microspheres.
Hardwick RA; Kulcinski D; Mansour V; Ishizawa L; Law P; Gee AP
J Hematother; 1992; 1(4):379-86. PubMed ID: 1345680
[TBL] [Abstract][Full Text] [Related]
30. Magnetic separation techniques: their application to medicine.
Kemshead JT; Ugelstad J
Mol Cell Biochem; 1985 May; 67(1):11-8. PubMed ID: 3894931
[TBL] [Abstract][Full Text] [Related]
31. Removal of tumour cells from bone marrow: an evaluation of the available techniques.
Treleaven JG; Kemshead JT
Hematol Oncol; 1985; 3(1):65-75. PubMed ID: 3886515
[TBL] [Abstract][Full Text] [Related]
32. Potential novel targets in breast cancer.
Rameshwar P
Curr Pharm Biotechnol; 2009 Feb; 10(2):148-53. PubMed ID: 19199946
[TBL] [Abstract][Full Text] [Related]
33. Elimination of malignant clonogenic breast cancer cells from human bone marrow.
Anderson IC; Shpall EJ; Leslie DS; Nustad K; Ugelstad J; Peters WP; Bast RC
Cancer Res; 1989 Aug; 49(16):4659-64. PubMed ID: 2663144
[TBL] [Abstract][Full Text] [Related]
34. Immunomagnetic manipulation of bone marrow and tumour cells: an update.
Kemshead JT; Elsom G; Patel K
Prog Clin Biol Res; 1990; 333():235-50; discussion 251. PubMed ID: 2408061
[TBL] [Abstract][Full Text] [Related]
35. Autologous bone marrow support and bone disease in metastatic breast cancer.
Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM
Can J Oncol; 1995 Jul; 5(2):369-75. PubMed ID: 8853509
[TBL] [Abstract][Full Text] [Related]
36. Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostine.
Balzarotti M; Grisanti S; Granzow K; Saladini A; Sala A; Nozza A; Molteni A; Passamonti F; Carlo-Stella C; Santoro A; Siena S
Semin Oncol; 1999 Apr; 26(2 Suppl 7):66-71. PubMed ID: 10348263
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
